期刊
SMALL
卷 15, 期 24, 页码 -出版社
WILEY-V C H VERLAG GMBH
DOI: 10.1002/smll.201901156
关键词
antitumor treatment; dichloroacetic acid; liposomes; MOF-Fe2+; oxidative stress
类别
资金
- National Key Research and Development Program of China [2018YFB1105400]
- National Natural Science Foundation of China [21708019]
- Thousand Talents Program for Young Researchers
- Natural Science Foundation of Jiangsu Province [BK20180334]
- Shuangchuang Program of Jiangsu Province
- Fundamental Research Funds for Central Universities
- Scientific Research Foundation of Graduate School of Nanjing University [2017ZDL04]
Cancer cells are susceptible to oxidative stress; therefore, selective elevation of intracellular reactive oxygen species (ROS) is considered as an effective antitumor treatment. Here, a liposomal formulation of dichloroacetic acid (DCA) and metal-organic framework (MOF)-Fe2+ (MD@Lip) has been developed, which can efficiently stimulate ROS-mediated cancer cell apoptosis in vitro and in vivo. MD@Lip can not only improve aqueous solubility of octahedral MOF-Fe2+, but also generate an acidic microenvironment to activate a MOF-Fe2+-based Fenton reaction. Importantly, MD@Lip promotes DCA-mediated mitochondrial aerobic oxidation to increase intracellular hydrogen peroxide (H2O2), which can be consequently converted to highly cytotoxic hydroxyl radicals (center dot OH) via MOF-Fe2+, leading to amplification of cancer cell apoptosis. Particularly, MD@Lip can selectively accumulate in tumors, and efficiently inhibit tumor growth with minimal systemic adverse effects. Therefore, liposome-based combination therapy of DCA and MOF-Fe2+ provides a promising oxidative stress-associated antitumor strategy for the management of malignant tumors.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据